Menu

Publications

2012

  1. Muraoka, S., Kume, H., Watanabe, S., Adachi, J., Kuwano, M., Sato, M., Kawasaki, N., Kodera, Y., Ishitobi, M., Inaji, H., Tomonaga, T. et al. (2012). A strategy for SRM-based verification of biomarker candidates discovered by iTRAQ method in limited breast cancer tissue samples. J Proteome Res 11, 4201-4210. DOI: 10.1021/pr300322q
  2. Narumi, R., Murakami, T., Kuga, T., Adachi, J., Shiromizu, T., Muraoka, S., Kume, H., Kodera, Y., Matsumoto, M., Nakayama, K., Tomonaga, T. et al. (2012). A Strategy for Large-Scale Phosphoproteomics and SRM-Based Validation of Human Breast Cancer Tissue Samples. J Proteome Res 11, 5311-5322. DOI: 10.1021/pr3005474
  3. Katada, K., Tomonaga, T., Satoh, M., Matsushita, K., Tonoike, Y., Kodera, Y., Hanazawa, T., Nomura, F., and Okamoto, Y. (2012). Plectin promotes migration and invasion of cancer cells and is a novel prognostic marker for head and neck squamous cell carcinoma. J Proteomics 75, 1803-1815. DOI: 10.1016/j.jprot.2011.12.018
  4. Yoshida, Y., Nameta, M., Kuwano, M., Zhang, Y., Bo, X., Magdeldin, S., Cui, Z., Fujinaka, H., Yaoita, E., Tomonaga, T., et al. (2012). Proteomic approach to human kidney glomerulus prepared by laser microdissection from frozen biopsy specimens: exploration of proteome after removal of blood-derived proteins. Proteomics Clin Appl 6, 412-417. DOI: 10.1002/prca.201200016
  5. Guo, F., Hiroshima, K., Wu, D., Satoh, M., Abulazi, M., Yoshino, I., Tomonaga, T., Nomura, F., and Nakatani, Y. (2012). Prohibitin in squamous cell carcinoma of the lung: its expression and possible clinical significance. Hum Pathol. DOI: 10.1016/j.humpath.2011.10.006
  6. Hosako, M., Muto, T., Nakamura, Y., Tsuta, K., Tochigi, N., Tsuda, H., Asamura, H., Tomonaga, T., Kawai, A., and Kondo, T. (2012). Proteomic study of malignant pleural mesothelioma by laser microdissection and two-dimensional difference gel electrophoresis identified cathepsin D as a novel candidate for a differential diagnosis biomarker. J Proteomics 75, 833-844. DOI: 10.1016/j.jprot.2011.09.026 
  7. Kikkawa, S., Sogawa, K., Satoh, M., Umemura, H., Kodera, Y., Matsushita, K., Tomonaga, T., Miyazaki, M., Yokosuka, O., and Nomura, F. (2012). Identification of a Novel Biomarker for Biliary Tract Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry. Int J Proteomics 2012, 108609. DOI: 10.1155/2012/108609
  8. Kimura, A., Sogawa, K., Satoh, M., Kodera, Y., Yokosuka, O., Tomonaga, T., and Nomura, F. (2012). The application of a three-step serum proteome analysis for the discovery and identification of novel biomarkers of hepatocellular carcinoma. Int J Proteomics 2012, 623190. DOI: 10.1155/2012/623190
  9. Matsushita, K., Kajiwara, T., Tamura, M., Satoh, M., Tanaka, N., Tomonaga, T., Matsubara, H., Shimada, H., Yoshimoto, R., Ito, A., et al. (2012). SAP155-Mediated Splicing of FUSE-Binding Protein-Interacting Repressor Serves as a Molecular Switch for c-myc Gene Expression. Mol Cancer Res 10, 787-799. DOI: 10.1158/1541-7786.MCR-11-0462
  10. Nomura, F., Sogawa, K., Noda, K., Seimiya, M., Matsushita, K., Miura, T., Tomonaga, T., Yoshitomi, H., Imazeki, F., Takizawa, H., et al. (2012). Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma. Biochem Biophys Res Commun 421, 837-843. DOI: 10.1016/j.bbrc.2012.04.099
  11. Sugihara, Y., Taniguchi, H., Kushima, R., Tsuda, H., Kubota, D., Ichikawa, H., Sakamoto, K., Nakamura, Y., Tomonaga, T., Fujita, S., et al. (2012). Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancer. J Proteomics 75, 5342-5355.  DOI: 10.1016/j.jprot.2012.06.013
  12. Uebi, T., Itoh, Y., Hatano, O., Kumagai, A., Sanosaka, M., Sasaki, T., Sasagawa, S., Doi, J., Tatsumi, K., Mitamura, K., Tomonaga, T. et al. (2012). Involvement of SIK3 in Glucose and Lipid Homeostasis in Mice. PLoS One 7, e37803. DOI: 10.1371/journal.pone.0037803